ESR1 and cancer: Although it accounts for only 15–20% of all BC, it constitutes a highly heterogeneous cancer disease due to its molecular and histological characteristics mainly represented by the ER expression, which is the unique feature currently used for patient stratification and for setting anti-hormonal treatments.